US Stock MarketDetailed Quotes
ESLA Estrella Immunopharma
- 1.015
- -0.035-3.33%
Close May 17 16:00 ET
- 0.990
- -0.025-2.46%
Post 19:53 ET
36.92MMarket Cap-2537P/E (TTM)
1.120High0.860Low24.57KVolume1.000Open1.050Pre Close24.73KTurnover0.23%Turnover RatioLossP/E (Static)36.38MShares33.00052wk High4.34P/B10.76MFloat Cap0.86052wk Low--Dividend TTM10.60MShs Float33.000Historical High--Div YieldTTM24.76%Amplitude0.860Historical Low1.006Avg Price1Lot Size
About Estrella Immunopharma Company
Estrella Immunopharma, Inc. operates as a pre-clinical stage biopharmaceutical company, which engages in the development of T-cell therapies with the capacity to address treatment and safety challenges for patients with blood cancers and solid tumors. The company is headquartered in Emeryville, CA.
Company Profile
SymbolESLA
Company NameEstrella Immunopharma
Listing DateSep 14, 2021
CEODr. Cheng Liu, PhD
MarketNASDAQ
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address5858 Horton Street,Suite 370
CityEmeryville
ProvinceCalifornia
CountryUnited States of America
Zip Code94608
Phone1-510-318-9098
Websitehttps://www.estrellabio.com
Company Executives
- Name
- Position
- Salary
- Dr. Cheng Liu, PhD
- Chief Executive Officer, President and Director
- --
- Jiandong Xu
- Chief Financial Officer
- --
- Qian Yang
- Chief Operating Officer
- --
- Pei Xu
- Independent Director
- --
- Janelle Wu
- Independent Director
- --
- Fan Wu
- Independent Director
- --
- Dr. Marsha Roberts
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg